Accepting New Patients
About me
Javier Alcid Duron Tabora, MD, is an endocrinologist specializing in diabetes and metabolic disorders with Atlantic Health. Board-certified in internal medicine by the American Board of Internal Medicine, he has more than five years of experience diagnosing and treating disorders of the glands and hormones, including diabetes, thyroid, adrenal and metabolic conditions. He is dedicated to providing compassionate, personalized care to all patients and ensuring they are educated about their condition and treatment.
Dr. Duron earned his medical degree from Universidad Nacional Autónoma de Honduras in Tegucigalpa, Honduras, then completed his internal medicine residency at Morristown Medical Center and his endocrinology, diabetes and metabolism fellowship at Rush University of Chicago. Prior to joining Atlantic Health, he gained extensive clinical and academic experience in both the United States and Honduras. He has also been actively involved in medical education as volunteer faculty at the University of Kentucky College of Medicine and as a preceptor at the University of Pikeville–Kentucky College of Osteopathic Medicine. He has authored peer-reviewed publications and is a participating provider of the Atlantic Accountable Care Organization.
SPECIALTIES
Endocrinology
AFFILIATIONS
Atlantic Medical Group
Newton Medical Center
Where to see me
Insurance
Please contact the practice to confirm your health plan is accepted.
Aetna
Aetna Better Health
AHS PPO
Amerihealth Caritas
Brighton Create
Brighton Healthplan Solutions
Centivo
Cigna
ClaimDoc LLC
Claim Watcher
Education & Experience
TRAINING
Universidad Nacional Autonoma de Honduras
Medical School
Morristown Medical Center
Residency
Rush Day Hospital Rush University Medical Center
Fellowship
BOARD CERTIFICATIONS
Patient Reviews
4.9
- 5.0Jun 26, 2026I was impressed by his thoroughness & thoughtfulness.
- 5.0Jun 22, 2026Very professional friendly
- 5.0Jun 22, 2026Doctor explained clearly and asked numerous times if I understood
- 5.0Apr 19, 2026GOOD
- 5.0Apr 19, 2026GOOD
